Since March 2016, Ambry has been collecting data samples from researchers through the data sharing program AmbryShare, with a goal of improving scientific research aimed at making more tailored treatments and/or cures available to clinicians and their patients. Now anyone can participate in a research study and choose to either submit an e-consent…
The New England Journal of Medicine (NEJM) recently released a study, which concluded that 11.8% of metastatic prostate cancer cases were caused by germline gene mutations leading to hereditary prostate cancer. The study involved 692 men from the United States and United Kingdom who have documented metastatic prostate cancer. Eighty-four germline…